Global Intravenous Immune Globulin Therapies Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Intravenous Immune Globulin Therapies Market Overview

• 1.1 Product Overview and Scope of Intravenous Immune Globulin Therapies
• 1.2 Classification of Intravenous Immune Globulin Therapies by Types
  • 1.2.1 Global Intravenous Immune Globulin Therapies Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Intravenous Immune Globulin Therapies Revenue Market Share by Types in 2018
  • 1.2.3 Liquid Form
  • 1.2.4 Lyophilized Powder Form
• 1.3 Global Intravenous Immune Globulin Therapies Market by Application
  • 1.3.1 Global Intravenous Immune Globulin Therapies Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Immunodeficiency
  • 1.3.3 Autoimmune Disease
  • 1.3.4 Acute Infection
• 1.4 Global Intravenous Immune Globulin Therapies Market by Regions
  • 1.4.1 Global Intravenous Immune Globulin Therapies Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Intravenous Immune Globulin Therapies Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Intravenous Immune Globulin Therapies Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Intravenous Immune Globulin Therapies Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Intravenous Immune Globulin Therapies Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Intravenous Immune Globulin Therapies Status and Prospect (2014-2024)
• 1.5 Global Market Size of Intravenous Immune Globulin Therapies (2014-2024)

2 Manufacturers Profiles

• 2.1 Baxter
  • 2.1.1 Business Overview
  • 2.1.2 Intravenous Immune Globulin Therapies Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Baxter Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Grifols
  • 2.2.1 Business Overview
  • 2.2.2 Intravenous Immune Globulin Therapies Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Grifols Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 CSL Plasma
  • 2.3.1 Business Overview
  • 2.3.2 Intravenous Immune Globulin Therapies Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 CSL Plasma Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Octapharma
  • 2.4.1 Business Overview
  • 2.4.2 Intravenous Immune Globulin Therapies Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Octapharma Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Biotest
  • 2.5.1 Business Overview
  • 2.5.2 Intravenous Immune Globulin Therapies Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Biotest Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Kedrion
  • 2.6.1 Business Overview
  • 2.6.2 Intravenous Immune Globulin Therapies Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Kedrion Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Kamada
  • 2.7.1 Business Overview
  • 2.7.2 Intravenous Immune Globulin Therapies Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Kamada Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 China Biologic Products Holdings
  • 2.8.1 Business Overview
  • 2.8.2 Intravenous Immune Globulin Therapies Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 China Biologic Products Holdings Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 Hualan Biological Engineering
  • 2.9.1 Business Overview
  • 2.9.2 Intravenous Immune Globulin Therapies Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Hualan Biological Engineering Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 Sichuan Yuanda Shuyang Pharmaceutical
  • 2.10.1 Business Overview
  • 2.10.2 Intravenous Immune Globulin Therapies Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 Sichuan Yuanda Shuyang Pharmaceutical Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2018)

3 Global Intravenous Immune Globulin Therapies Market Competition, by Players

• 3.1 Global Intravenous Immune Globulin Therapies Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Intravenous Immune Globulin Therapies Players Market Share
  • 3.2.2 Top 10 Intravenous Immune Globulin Therapies Players Market Share
• 3.3 Market Competition Trend

4 Global Intravenous Immune Globulin Therapies Market Size by Regions

• 4.1 Global Intravenous Immune Globulin Therapies Revenue and Market Share by Regions
• 4.2 North America Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
• 4.3 Europe Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
• 4.5 South America Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)

5 North America Intravenous Immune Globulin Therapies Revenue by Countries

• 5.1 North America Intravenous Immune Globulin Therapies Revenue by Countries (2014-2019)
• 5.2 USA Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
• 5.3 Canada Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)

6 Europe Intravenous Immune Globulin Therapies Revenue by Countries

• 6.1 Europe Intravenous Immune Globulin Therapies Revenue by Countries (2014-2019)
• 6.2 Germany Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
• 6.3 UK Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
• 6.4 France Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
• 6.5 Russia Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
• 6.6 Italy Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Intravenous Immune Globulin Therapies Revenue by Countries

• 7.1 Asia-Pacific Intravenous Immune Globulin Therapies Revenue by Countries (2014-2019)
• 7.2 China Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
• 7.3 Japan Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
• 7.4 Korea Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
• 7.5 India Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)

8 South America Intravenous Immune Globulin Therapies Revenue by Countries

• 8.1 South America Intravenous Immune Globulin Therapies Revenue by Countries (2014-2019)
• 8.2 Brazil Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Intravenous Immune Globulin Therapies by Countries

• 9.1 Middle East and Africa Intravenous Immune Globulin Therapies Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
• 9.3 UAE Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)

10 Global Intravenous Immune Globulin Therapies Market Segment by Type

• 10.1 Global Intravenous Immune Globulin Therapies Revenue and Market Share by Type (2014-2019)
• 10.2 Global Intravenous Immune Globulin Therapies Market Forecast by Type (2019-2024)
• 10.3 Liquid Form Revenue Growth Rate (2014-2024)
• 10.4 Lyophilized Powder Form Revenue Growth Rate (2014-2024)

11 Global Intravenous Immune Globulin Therapies Market Segment by Application

• 11.1 Global Intravenous Immune Globulin Therapies Revenue Market Share by Application (2014-2019)
• 11.2 Intravenous Immune Globulin Therapies Market Forecast by Application (2019-2024)
• 11.3 Immunodeficiency Revenue Growth (2014-2019)
• 11.4 Autoimmune Disease Revenue Growth (2014-2019)
• 11.5 Acute Infection Revenue Growth (2014-2019)

12 Global Intravenous Immune Globulin Therapies Market Size Forecast (2019-2024)

• 12.1 Global Intravenous Immune Globulin Therapies Market Size Forecast (2019-2024)
• 12.2 Global Intravenous Immune Globulin Therapies Market Forecast by Regions (2019-2024)
• 12.3 North America Intravenous Immune Globulin Therapies Revenue Market Forecast (2019-2024)
• 12.4 Europe Intravenous Immune Globulin Therapies Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Intravenous Immune Globulin Therapies Revenue Market Forecast (2019-2024)
• 12.6 South America Intravenous Immune Globulin Therapies Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Intravenous Immune Globulin Therapies Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology